Calton & Associates’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$142K	Buy	+10,890	New	+$142K	0.02%	372
2018 Q1	–	Sell	-28	Closed	–	–	388
2017 Q4	$0	Buy	+28	New	–	﹤0.01%	1469